Open AccessFactors Associated With Complete Remission After Rituximab Therapy for Pemphigus
Author(s) -
Carolyn J. Kushner,
Shiyu Wang,
Napatra Tovanabutra,
Donald E. Tsai,
Victoria P. Werth,
Aimee Payne
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2019.3236
Subject(s) - medicine , rituximab , pemphigus , retrospective cohort study , regimen , cohort , surgery , immunology , lymphoma
Rituximab has emerged as a front-line therapy for pemphigus, but prognostic factors for achieving complete remission off therapy (CROT) with oral systemic agents remain unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom